Regeneron Pharmaceuticals Inc.’s Covid-19 antibody drug was authorized Saturday by U.S. health regulators, the second cleared this month to treat patients who aren’t hospitalized but are at high risk of developing severe disease.

The Food and Drug Administration cleared the antibody drug cocktail for use treating mild to moderate Covid-19 patients 12 years of age and older, including people older than 65 years.

Regeneron’s…

This post first appeared on wsj.com

You May Also Like

45 bags of human remains found in western Mexico amid search for missing call center workers

Forty-five bags filled with human remains were found in the western Mexican…

Homes Became Offices, and Offices Became Homes

About 28,000 new rental apartments were created in the United States by…

Private Fox News text messages, testimony and emails released in Dominion suit

Hundreds of pages of testimony, private text messages and emails from top…

Beyoncé says new ‘Cowboy Carter’ album inspired by backlash to her entering country genre

Beyoncé shared an Instagram post on Tuesday explaining the inspiration behind her…